{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:07:41Z","timestamp":1777957661268,"version":"3.51.4"},"reference-count":131,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundo Europeu de Desenvolvimento Regional (FEDER)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"Faculty of Medicine, University of Porto (FMUP)","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The anti-epileptic drug lamotrigine (LTG) has been widely used to treat various neurological disorders, including epilepsy and bipolar disorder. However, its precise mechanism of action in the central nervous system (CNS) still needs to be determined. Recent studies have highlighted the involvement of LTG in modulating the activity of voltage-gated ion channels, particularly those related to the inhibition of neuronal excitability. Additionally, LTG has been found to have neuroprotective effects, potentially through the inhibition of glutamate release and the enhancement of GABAergic neurotransmission. LTG\u2019s unique mechanism of action compared to other anti-epileptic drugs has led to the investigation of its use in treating other CNS disorders, such as neuropathic pain, PTSD, and major depressive disorder. Furthermore, the drug has been combined with other anti-epileptic drugs and mood stabilizers, which may enhance its therapeutic effects. In conclusion, LTG\u2019s potential to modulate multiple neurotransmitters and ion channels in the CNS makes it a promising drug for treating various neurological disorders. As our understanding of its mechanism of action in the CNS continues to evolve, the potential for the drug to be used in new indications will also be explored.<\/jats:p>","DOI":"10.3390\/ijms24076050","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T04:37:28Z","timestamp":1679546248000},"page":"6050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Understanding Lamotrigine\u2019s Role in the CNS and Possible Future Evolution"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-5874","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Costa","sequence":"first","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, s\/n, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, s\/n, 4200-450 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, s\/n, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, s\/n, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond","volume":"35","author":"Klein","year":"2021","journal-title":"CNS Drugs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fneur.2021.674182","article-title":"The Effect of Anti-Seizure Medications on the Propagation of Epileptic Activity: A Review","volume":"12","author":"Khateb","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_3","unstructured":"Subbarao, B.S., Silverman, A., and Eapen, B.C. (2022). Seizure Medications, StatPearls."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/epi.12172","article-title":"Network-Specific Mechanisms May Explain the Paradoxical Effects of Carbamazepine and Phenytoin","volume":"54","author":"Thomas","year":"2013","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/mol.116.106401","article-title":"Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States","volume":"91","author":"Jo","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bcp.12205","article-title":"Low Threshold T-Type Calcium Channels as Targets for Novel Epilepsy Treatments","volume":"77","author":"Powell","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kazmierska-Grebowska, P., Siwiec, M., Sowa, J.E., Caban, B., Kowalczyk, T., Bocian, R., and Maciver, M.B. (2021). Lamotrigine Attenuates Neuronal Excitability, Depresses GABA Synaptic Inhibition, and Modulates Theta Rhythms in Rat Hippocampus. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202111.0067.v2"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0883073897012001031","article-title":"Antiepileptic Drug Cellular Mechanisms of Action: Where Does Lamotrigine Fit In?","volume":"12","author":"Coulter","year":"1997","journal-title":"J. Child. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.jcp.0000088915.02635.e8","article-title":"Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders","volume":"23","author":"Ketter","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fct.2018.05.022","article-title":"Topiramate Mitigates 3-Nitropropionic Acid-Induced Striatal Neurotoxicity via Modulation of AMPA Receptors","volume":"118","author":"Shalaby","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"ref_11","unstructured":"Olsen, R.W., and DeLorey, T.M. (1999). Basic Neurochemistry: Molecular, Cellular and Medical Aspects, Lippincott-Raven."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The Mechanism of Action of Retigabine (Ezogabine), a First-in-Class K+ Channel Opener for the Treatment of Epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"ref_13","first-page":"392","article-title":"Overview of Drugs Used For Epilepsy and Seizures: Etiology, Diagnosis, and Treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"Pharm. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157015909788848866","article-title":"Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management","volume":"7","author":"Rosenfeld","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41598-017-02525-2","article-title":"Efficacy and Tolerability of Second and Third Generation Anti-Epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis","volume":"7","author":"Zhuo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","article-title":"The Association Between Antiepileptic Drugs and Bone Disease","volume":"3","author":"Pack","year":"2003","journal-title":"Epilepsy Curr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care","volume":"7","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic Drug Interactions-Principles and Clinical Implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why Are Antiepileptic Drugs Used for Nonepileptic Conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1101\/cshperspect.a022780","article-title":"Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet","volume":"6","author":"Rogawski","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_21","first-page":"157","article-title":"Pharmacokinetic and Pharmacodynamic Properties of the New AEDs: A Review Article","volume":"12","author":"Ghaffarpour","year":"2013","journal-title":"Iran J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety Review of Adult Clinical Trial Experience with Lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ane.13312","article-title":"Evidence-Based Anti-Seizure Monotherapy in Newly Diagnosed Epilepsy: A New Approach","volume":"142","author":"Kimland","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"ref_24","unstructured":"FDA (2023, February 07). Highlights of Prescribing Information: Lamotrigine, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020241s045s051lbl.pdf."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1528-1157.1996.tb00038.x","article-title":"Lamotrigine High-Dose Tolerability and Safety in Patients with Epilepsy: A Double-Blind, Placebo-Controlled, Eleven-Week Study","volume":"37","author":"Matsuo","year":"1996","journal-title":"Epilepsia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70047-1","article-title":"Lamotrigine for the Treatment of Epilepsy in Childhood","volume":"127","author":"Besag","year":"1995","journal-title":"J. Pediatr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.4103\/0019-5545.196974","article-title":"Clinical Practice Guidelines for Management of Bipolar Disorder","volume":"59","author":"Shah","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/epi4.12495","article-title":"A New Rapid Titration Protocol for Lamotrigine That Reduces the Risk of Skin Rash","volume":"6","author":"Jang","year":"2021","journal-title":"Epilepsia Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, Toxicology and Safety of Lamotrigine in Epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kara\u00b4zniewiczkara\u00b4zniewicz-\u0141ada, M., G\u0142\u00f3wka, A.K., Mikulska, A.A., G\u0142\u00f3wka, F.K., Kara\u00b4zniewicz-\u0141ada, K., G\u0142\u00f3wka, M., Mikulska, A.K., G\u0142\u00f3wka, A.A., Pharmacokinetic, F.K., and Pl, A.A.M. (2021). Pharmacokinetic Drug\u2013Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179582"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2018.03.003","article-title":"Time Course of Reversal of Valproate-Mediated Inhibition of Lamotrigine","volume":"57","author":"Leary","year":"2018","journal-title":"Seizure"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lee, J.W., and Dworetzky, B. (2010). Rational Polytherapy with Antiepileptic Drugs. Pharmaceuticals, 3.","DOI":"10.3390\/ph3082362"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/bcp.13973","article-title":"The Interaction between Rifampicin and Lamotrigine: A Case Report","volume":"85","author":"Wimpelmann","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107162","DOI":"10.1016\/j.yebeh.2020.107162","article-title":"Contraceptive Vaginal Ring Reduces Lamotrigine Levels","volume":"111","author":"King","year":"2020","journal-title":"Epilepsy Behav."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"McMillin, G.A., and Krasowski, M.D. (2016). Therapeutic Drug Monitoring of Newer Antiepileptic Drugs. Clin. Chall. Ther. Drug Monit. Spec. Popul. Physiol. Cond. Pharm., 101\u2013134.","DOI":"10.1016\/B978-0-12-802025-8.00005-2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.108.144709","article-title":"Modulation of Sodium Channel Inactivation Gating by a Novel Lactam: Implications for Seizure Suppression in Chronic Limbic Epilepsy","volume":"328","author":"Jones","year":"2009","journal-title":"J. Pharm. Exp."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.bjp.0701221","article-title":"Characterization of Lamotrigine Inhibition of Na+ Channels in Rat Hippocampal Neurones","volume":"121","author":"Kuo","year":"1997","journal-title":"Br. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/bph.12534","article-title":"Properties of Human Brain Sodium Channel \u03b1-Subunits Expressed in HEK293 Cells and Their Modulation by Carbamazepine, Phenytoin and Lamotrigine","volume":"171","author":"Qiao","year":"2014","journal-title":"Br. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00373920","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones","volume":"430","author":"Xie","year":"1995","journal-title":"Pfluegers Archiv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(96)00384-7","article-title":"A Calcium Antagonistic Effect of the New Antiepileptic Drug Lamotrigine","volume":"7","author":"Wegerer","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pbb.2012.01.019","article-title":"Lamotrigine Treatment Reverses Depressive-like Behavior and Alters BDNF Levels in the Brains of Maternally Deprived Adult Rats","volume":"101","author":"Abelaira","year":"2012","journal-title":"Pharm. Biochem. Behav."},{"key":"ref_42","unstructured":"Betchel, N.T., Fariba, K.A., and Saadabadi, A. (2022). Lamotrigine. Essence Analg. Analg., 306\u2013309."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2018.10.016","article-title":"The Pharmacological Management of Lennox-Gastaut Syndrome and Critical Literature Review","volume":"63","author":"Verrotti","year":"2018","journal-title":"Seizure"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","article-title":"Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11096-018-0641-9","article-title":"Comparative Efficacy of Antiepileptic Drugs for Patients with Generalized Epileptic Seizures: Systematic Review and Network Meta-Analyses","volume":"40","author":"Ayres","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.seizure.2018.06.013","article-title":"Comparison of Lamotrigine and Oxcarbazepine Monotherapy for Pediatric Focal Epilepsy: An Observational Study","volume":"60","author":"Hur","year":"2018","journal-title":"Seizure"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Nevitt, S.J., Sudell, M., Cividini, S., Marson, A.G., and Tudur Smith, C. (2022). Antiepileptic Drug Monotherapy for Epilepsy: A Network Meta-Analysis of Individual Participant Data. Cochrane Database Syst. Rev., 2022.","DOI":"10.1002\/14651858.CD011412.pub4"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-017-0441-0","article-title":"Sodium Channel Blockers in the Treatment of Epilepsy","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wahab, A. (2010). Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals, 3.","DOI":"10.3390\/ph3072090"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from Oxcarbazepine and Carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Poolos, N.P. (2012). Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Ion Channelopathy in Epilepsy, Jasper\u2019s Basic Mechanisms of the Epilepsies.","DOI":"10.1093\/med\/9780199746545.003.0007"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrd3576","article-title":"Exploring HCN Channels as Novel Drug Targets","volume":"10","author":"Postea","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"807202","DOI":"10.3389\/fnmol.2022.807202","article-title":"The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review","volume":"15","author":"Kessi","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pbiomolbio.2021.06.002","article-title":"Ih from Synapses to Networks: HCN Channel Functions and Modulation in Neurons","volume":"166","author":"Combe","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s13311-017-0538-7","article-title":"HCN Channel Targets for Novel Antidepressant Treatment","volume":"14","author":"Ku","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/sj.npp.1301387","article-title":"Increased Anterior Cingulate\/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression","volume":"32","author":"Frye","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharm. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1574886315666200225111057","article-title":"Delirium Secondary to Lamotrigine Toxicity","volume":"15","author":"Sanchez","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in Psychiatric Disorders","volume":"74","author":"Reid","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/npr2.12228","article-title":"The Effectiveness of Lamotrigine for Persistent Depressive Disorder: A Case Report","volume":"42","author":"Matsuzaka","year":"2022","journal-title":"Neuropsychopharmacol. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Ko\u015bmider, K., Kamieniak, M., Czuczwar, S.J., and Miziak, B. (2023). Second Generation of Antiepileptic Drugs and Oxidative Stress. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043873"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1742-7843.2009.00499.x","article-title":"Effect of Carbamazepine and Lamotrigine on Cognitive Function and Oxidative Stress in Brain during Chemical Epileptogenesis in Rats","volume":"106","author":"Arora","year":"2010","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ijnp\/pyab080","article-title":"Effects of Lamotrigine and Topiramate on Glial Properties in an Astrocyte-Microglia Co-Culture Model of Inflammation","volume":"25","author":"Faustmann","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphar.2015.00242","article-title":"Management of Bipolar Depression with Lamotrigine: An Antiepileptic Mood Stabilizer","volume":"6","author":"Prabhavalkar","year":"2015","journal-title":"Front. Pharm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000542-199802000-00028","article-title":"Effects of Intrathecally Administered Lamotrigine, a Glutamate Release Inhibitor, on Short- and Long-Term Models of Hyperalgesia in Rats","volume":"88","author":"Klamt","year":"1998","journal-title":"Anesthesiology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S1461145712000429","article-title":"Neuroprotective Effects of the Mood Stabilizer Lamotrigine against Glutamate Excitotoxicity: Roles of Chromatin Remodelling and Bcl-2 Induction","volume":"16","author":"Leng","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lin, C.H., Ho, C.J., Lu, Y.T., and Tsai, M.H. (2021). Response to Sodium Channel Blocking Antiseizure Medications and Coding Polymorphisms of Sodium Channel Genes in Taiwanese Epilepsy Patients. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02395-2"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Huang, Y.Y., Liu, Y.C., Lee, C.T., Lin, Y.C., Wang, M.L., Yang, Y.P., Chang, K.Y., and Chiou, S.H. (2016). Revisiting the Lamotrigine-Mediated Effect on Hippocampal GABAergic Transmission. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071191"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.injury.2021.08.004","article-title":"Biochemical, Pathological and Ultrastructural Investigation of Whether Lamotrigine Has Neuroprotective Efficacy against Spinal Cord Ischemia Reperfusion Injury","volume":"52","author":"Kahveci","year":"2021","journal-title":"Injury"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"107915","DOI":"10.1016\/j.yebeh.2021.107915","article-title":"Protective Effects of Lamotrigine and Vitamin B12 on Pentylenetetrazole-Induced Epileptogenesis in Rats","volume":"118","author":"Filiz","year":"2021","journal-title":"Epilepsy Behav."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.4088\/JCP.v65n0610","article-title":"The Current Understanding of Lamotrigine as a Mood Stabilizer","volume":"65","author":"Hahn","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7810196","DOI":"10.1155\/2016\/7810196","article-title":"Lamotrigine Reduces Inflammatory Response and Ameliorates Executive Function Deterioration in an Alzheimer\u2019s-Like Mouse Model","volume":"2016","author":"Wang","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/2230-973X.143125","article-title":"Formulation Development and Evaluation of Fast Disintegrating Tablets of Lamotrigine Using Liqui-Solid Technique","volume":"4","author":"Koteswari","year":"2014","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2045125316672573","article-title":"Variation in Dose and Plasma Level of Lamotrigine in Patients Discharged from a Mental Health Trust","volume":"7","author":"Dzahini","year":"2017","journal-title":"Adv. Psychopharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1177\/0883073897012001041","article-title":"Lamotrigine: Pharmacokinetics","volume":"12","author":"Garnett","year":"1997","journal-title":"J. Child. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/bcp.12984","article-title":"Pharmacokinetics of Lamotrigine and Its Metabolite N-2-glucuronide: Influence of Polymorphism of UDP-glucuronosyltransferases and Drug Transporters","volume":"82","author":"Milosheska","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","article-title":"Influence of UDP-Glucuronosyltransferase Polymorphisms on Valproic Acid Pharmacokinetics in Chinese Epilepsy Patients","volume":"68","author":"Chu","year":"2012","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"108517","DOI":"10.1016\/j.yebeh.2021.108517","article-title":"The Importance of Drug Titration in the Management of Patients with Epilepsy","volume":"128","author":"Seiden","year":"2022","journal-title":"Epilepsy Behav."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","article-title":"Lamotrigine and Therapeutic Drug Monitoring: Retrospective Survey Following the Introduction of a Routine Service","volume":"46","author":"Morris","year":"1998","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FPC.0000000000000397","article-title":"PharmGKB Summary: Lamotrigine Pathway, Pharmacokinetics and Pharmacodynamics","volume":"30","author":"Callisto","year":"2020","journal-title":"Pharm. Genom."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1080\/21655979.2022.2036916","article-title":"Effects of Genetic Polymorphism of Drug-Metabolizing Enzymes on the Plasma Concentrations of Antiepileptic Drugs in Chinese Population","volume":"13","author":"Zhao","year":"2022","journal-title":"Bioengineered"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (Lamictal) in Refractory Trigeminal Neuralgia: Results from a Double-Blind Placebo Controlled Crossover Trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.17712\/nsj.2015.2.20140501","article-title":"Update on Neuropathic Pain Treatment for Trigeminal Neuralgia: The Pharmacological and Surgical Options","volume":"20","year":"2015","journal-title":"Neurosciences"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society","volume":"19","author":"Boulanger","year":"2014","journal-title":"Pain Res. Manag. J. Can. Pain Soc."},{"key":"ref_85","first-page":"e25905","article-title":"Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment","volume":"14","author":"Motwani","year":"2022","journal-title":"Cureus"},{"key":"ref_86","first-page":"CD006044","article-title":"Lamotrigine for Chronic Neuropathic Pain and Fibromyalgia in Adults","volume":"2013","author":"Wiffen","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"240","DOI":"10.9758\/cpn.2014.12.3.240","article-title":"Post-Traumatic Stress Disorder Symptoms in a Female Patient Following Repeated Teasing: Treatment with Gabapentin and Lamotrigine and the Possible Role of Sensitization","volume":"12","author":"Kishimoto","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/WNF.0000000000000477","article-title":"Lamotrigine for Treating Anger in Veterans with Posttraumatic Stress Disorder","volume":"44","author":"Thompson","year":"2021","journal-title":"Clin. Neuropharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1034\/j.1600-0447.2001.00237.x","article-title":"Post-Traumatic Stress Disorder: A Review of Psychobiology and Pharmacotherapy","volume":"104","author":"Hageman","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/appi.ajp.2018.17091006","article-title":"The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial","volume":"175","author":"Crawford","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"655079","DOI":"10.3389\/fpsyt.2021.655079","article-title":"Lamotrigine Reduces Stress Symptoms of Chronic Anxiety in the Times of the Covid-19 Natural Catastrophe-A Case Report","volume":"12","author":"Pham","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3345\/kjp.2017.60.6.189","article-title":"Effects of Lamotrigine on Attention-Deficit Hyperactivity Disorder in Pediatric Epilepsy Patients","volume":"60","author":"Han","year":"2017","journal-title":"Korean J. Pediatr."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-017-0585-1","article-title":"The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity","volume":"38","author":"Verrotti","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/0269881113493365","article-title":"Lamotrigine for Attention Deficit-Hyperactivity Disorder Comorbid with Mood Disorders: A Case Series","volume":"28","author":"Er","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fpsyt.2021.660432","article-title":"Comorbid Bipolar and Alcohol Use Disorder\u2014A Therapeutic Challenge","volume":"12","author":"Grunze","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Wilkowska, A., Wiglusz, M.S., Jakuszkowiak-Wojten, K., and Cuba\u0142a, W.J. (2022). Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review. Cells, 11.","DOI":"10.3390\/cells11040645"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","article-title":"Lamotrigine Reduces Migraine Aura and Migraine Attacks in Patients with Migraine with Aura","volume":"76","author":"Lampl","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/JCNSD.S9049","article-title":"Preventive Agents for Migraine: Focus on the Antiepileptic Drugs","volume":"4","author":"Shahien","year":"2012","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","article-title":"Lamotrigine versus Placebo in the Prophylaxis of Migraine with and without Aura","volume":"17","author":"Steiner","year":"1997","journal-title":"Cephalalgia"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2018.10.028","article-title":"Lamotrigine Attenuates the Motivation to Self-Administer Ketamine and Prevents Cue- and Prime-Induced Reinstatement of Ketamine-Seeking Behavior in Rats","volume":"194","author":"Lee","year":"2019","journal-title":"Drug Alcohol. Depend."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2015.11.011","article-title":"Potential Benefit of Lamotrigine in Managing Ketamine Use Disorder","volume":"87","author":"Huang","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/s10072-010-0297-2","article-title":"Therapeutic Strategies in Migraine Patients with Mood and Anxiety Disorders: Clinical Evidence","volume":"31","author":"Finocchi","year":"2010","journal-title":"Neurol. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1528-1167.2008.01989.x","article-title":"Blood\u2013Brain Barrier Damage and Brain Penetration of Antiepileptic Drugs: Role of Serum Proteins and Brain Edema","volume":"50","author":"Marchi","year":"2009","journal-title":"Epilepsia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","article-title":"Lamotrigine Is a Substrate for OCT1 in Brain Endothelial Cells","volume":"83","author":"Dickens","year":"2012","journal-title":"Biochem. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fneur.2021.674483","article-title":"The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13346-019-00622-5","article-title":"Nose-to-Brain Delivery of Lamotrigine-Loaded PLGA Nanoparticles","volume":"9","author":"Nigam","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/21691401.2021.1939709","article-title":"Lamotrigine Loaded PLGA Nanoparticles Intended for Direct Nose to Brain Delivery in Epilepsy: Pharmacokinetic, Pharmacodynamic and Scintigraphy Study","volume":"49","author":"Shah","year":"2021","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_108","unstructured":"(2023, February 03). Lamotrigine Loaded Nano-Liposomes Enhance Brain Selectivity in Vivo-PubMed, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/34602409\/."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2015.09.041","article-title":"Functionalized Nanocarrier Combined Seizure-Specific Vector with P-Glycoprotein Modulation Property for Antiepileptic Drug Delivery","volume":"74","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of Blood\u2013Brain Barrier in Brain Diseases and Related Systemic Nanoscale Brain-Targeting Drug Delivery Strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1039\/D2SC03298H","article-title":"Dual Targeting Nanoparticles for Epilepsy Therapy","volume":"13","author":"Hou","year":"2022","journal-title":"Chem. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1039\/D1NR05825H","article-title":"Screening On-Chip Fabricated Nanoparticles for Penetrating the Blood\u2013Brain Barrier","volume":"14","author":"Hou","year":"2022","journal-title":"Nanoscale"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/1541-7786.MCR-17-0662","article-title":"FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth","volume":"16","author":"Pellegrino","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Pellegrino, M., Rizza, P., Don\u00e0, A., Nigro, A., Ricci, E., Fiorillo, M., Perrotta, I., Lanzino, M., Giordano, C., and Bonofiglio, D. (2019). FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer. Cancers, 11.","DOI":"10.3390\/cancers11121858"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaad.2019.05.055","article-title":"Use of Antiepileptic Drugs and Risk of Skin Cancer: A Nationwide Case-Control Study","volume":"82","author":"Kristensen","year":"2020","journal-title":"J. Am. Acad. Derm."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2015.02.009","article-title":"Clinical Management of Seizures in Patients With Low-Grade Glioma","volume":"25","author":"Piotrowski","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-016-2056-6","article-title":"The Effects of Antiepileptic Drugs on the Growth of Glioblastoma Cell Lines","volume":"127","author":"Lee","year":"2016","journal-title":"J. Neurooncol."},{"key":"ref_118","first-page":"245","article-title":"Seizures and Cancer: Drug Interactions of Anticonvulsants with Chemotherapeutic Agents, Tyrosine Kinase Inhibitors and Glucocorticoids","volume":"3","author":"Vecht","year":"2016","journal-title":"Neurooncol. Pract."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fphar.2019.00832","article-title":"Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients with Epilepsy","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharm."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Pellegrino, M., Ricci, E., Ceraldi, R., Nigro, A., Bonofiglio, D., Lanzino, M., and Morelli, C. (2022). From HDAC to Voltage-Gated Ion Channels: What&rsquo;s Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer. Cancers, 14.","DOI":"10.3390\/cancers14184401"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.seizure.2020.07.014","article-title":"Sources of Lamotrigine Pharmacokinetic Variability: A Systematic Review of Population Pharmacokinetic Analyses","volume":"82","author":"Methaneethorn","year":"2020","journal-title":"Seizure"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2125.1997.00594.x","article-title":"Population Pharmacokinetics of Lamotrigine Monotherapy in Patients with Epilepsy: Retrospective Analysis of Routine Monitoring Data","volume":"43","author":"Hussein","year":"1997","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1528-1157.1998.tb01183.x","article-title":"Positive and Negative Psychotropic Effects of Lamotrigine in Patients with Epilepsy and Mental Retardation","volume":"39","author":"Ettinger","year":"1998","journal-title":"Epilepsia"},{"key":"ref_124","first-page":"96","article-title":"Lamotrigine and Stevens-Johnson Syndrome Prevention","volume":"51","author":"Edinoff","year":"2021","journal-title":"Psychopharmacol. Bull."},{"key":"ref_125","first-page":"5371854","article-title":"Lamotrigine-Valproic Acid Interaction Leading to Stevens\u2013Johnson Syndrome","volume":"2018","author":"Maldonado","year":"2018","journal-title":"Case Rep. Med."},{"key":"ref_126","first-page":"267","article-title":"Stevens\u2013Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): Immunologic Reactions","volume":"12","author":"Zimmerman","year":"2019","journal-title":"Oncol. Crit. Care"},{"key":"ref_127","first-page":"42","article-title":"Antiepileptic Drugs-Induced Stevens\u2013Johnson Syndrome: A Case Series","volume":"8","author":"Trivedi","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"ref_128","unstructured":"(2023, March 06). Lamictal (Lamotrigine): Drug Safety Communication-Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease|FDA, Available online: https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/lamictal-lamotrigine-drug-safety-communication-studies-show-increased-risk-heart-rhythm-problems."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2174\/1389450116666150531152047","article-title":"Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology","volume":"16","author":"Sartiani","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Scicchitano, P., Carbonara, S., Ricci, G., Mandurino, C., Locorotondo, M., Bulzis, G., Gesualdo, M., Zito, A., Carbonara, R., and Dentamaro, I. (2012). HCN Channels and Heart Rate. Molecules, 17.","DOI":"10.3390\/molecules17044225"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/epi4.12475","article-title":"FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory from the Ad Hoc ILAE\/AES Task Force","volume":"6","author":"French","year":"2021","journal-title":"Epilepsia Open"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:15Z","timestamp":1760122875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":131,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076050"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076050","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}